Skip to main content

DVT: a new era in anticoagulant therapy.

Publication ,  Journal Article
Mackman, N; Becker, RC
Published in: Arteriosclerosis, thrombosis, and vascular biology
March 2010

Duke Scholars

Published In

Arteriosclerosis, thrombosis, and vascular biology

DOI

EISSN

1524-4636

ISSN

1079-5642

Publication Date

March 2010

Volume

30

Issue

3

Start / End Page

369 / 371

Related Subject Headings

  • Venous Thrombosis
  • Thrombin
  • Thiophenes
  • Rivaroxaban
  • Pyridines
  • Morpholines
  • Mice, Knockout
  • Mice
  • Humans
  • Factor Xa Inhibitors
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Mackman, N., & Becker, R. C. (2010). DVT: a new era in anticoagulant therapy. Arteriosclerosis, Thrombosis, and Vascular Biology, 30(3), 369–371. https://doi.org/10.1161/atvbaha.110.203497
Mackman, Nigel, and Richard C. Becker. “DVT: a new era in anticoagulant therapy.Arteriosclerosis, Thrombosis, and Vascular Biology 30, no. 3 (March 2010): 369–71. https://doi.org/10.1161/atvbaha.110.203497.
Mackman N, Becker RC. DVT: a new era in anticoagulant therapy. Arteriosclerosis, thrombosis, and vascular biology. 2010 Mar;30(3):369–71.
Mackman, Nigel, and Richard C. Becker. “DVT: a new era in anticoagulant therapy.Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 3, Mar. 2010, pp. 369–71. Epmc, doi:10.1161/atvbaha.110.203497.
Mackman N, Becker RC. DVT: a new era in anticoagulant therapy. Arteriosclerosis, thrombosis, and vascular biology. 2010 Mar;30(3):369–371.

Published In

Arteriosclerosis, thrombosis, and vascular biology

DOI

EISSN

1524-4636

ISSN

1079-5642

Publication Date

March 2010

Volume

30

Issue

3

Start / End Page

369 / 371

Related Subject Headings

  • Venous Thrombosis
  • Thrombin
  • Thiophenes
  • Rivaroxaban
  • Pyridines
  • Morpholines
  • Mice, Knockout
  • Mice
  • Humans
  • Factor Xa Inhibitors